217 related articles for article (PubMed ID: 28926422)
21. The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity.
White SM; Murakami S; Yi C
Oncogene; 2019 Apr; 38(16):2899-2909. PubMed ID: 30617303
[TBL] [Abstract][Full Text] [Related]
22. S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells.
Li Y; Kong F; Wang J; Hu E; Wang R; Liu J; Xiao Q; Zhang W; He D; Xiao X
Oncotarget; 2016 Jun; 7(25):38133-38142. PubMed ID: 27203549
[TBL] [Abstract][Full Text] [Related]
23. YAP‑mediated crosstalk between the Wnt and Hippo signaling pathways (Review).
Jiang L; Li J; Zhang C; Shang Y; Lin J
Mol Med Rep; 2020 Nov; 22(5):4101-4106. PubMed ID: 33000236
[TBL] [Abstract][Full Text] [Related]
24. A splicing isoform of TEAD4 attenuates the Hippo-YAP signalling to inhibit tumour proliferation.
Qi Y; Yu J; Han W; Fan X; Qian H; Wei H; Tsai YH; Zhao J; Zhang W; Liu Q; Meng S; Wang Y; Wang Z
Nat Commun; 2016 Jun; 7():ncomms11840. PubMed ID: 27291620
[TBL] [Abstract][Full Text] [Related]
25. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.
Miyanaga A; Masuda M; Tsuta K; Kawasaki K; Nakamura Y; Sakuma T; Asamura H; Gemma A; Yamada T
J Thorac Oncol; 2015 May; 10(5):844-851. PubMed ID: 25902174
[TBL] [Abstract][Full Text] [Related]
26. The Hippo signaling pathway in gastric cancer.
Cao Z; An L; Han Y; Jiao S; Zhou Z
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):893-903. PubMed ID: 36924251
[TBL] [Abstract][Full Text] [Related]
27. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract][Full Text] [Related]
28. The Ambivalent Function of YAP in Apoptosis and Cancer.
Zhang X; Abdelrahman A; Vollmar B; Zechner D
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486435
[TBL] [Abstract][Full Text] [Related]
29. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
30. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.
Serrano I; McDonald PC; Lock F; Muller WJ; Dedhar S
Nat Commun; 2013; 4():2976. PubMed ID: 24356468
[TBL] [Abstract][Full Text] [Related]
32. Control of the hippo pathway by Set7-dependent methylation of Yap.
Oudhoff MJ; Freeman SA; Couzens AL; Antignano F; Kuznetsova E; Min PH; Northrop JP; Lehnertz B; Barsyte-Lovejoy D; Vedadi M; Arrowsmith CH; Nishina H; Gold MR; Rossi FM; Gingras AC; Zaph C
Dev Cell; 2013 Jul; 26(2):188-94. PubMed ID: 23850191
[TBL] [Abstract][Full Text] [Related]
33. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
34. Integration of Hippo-YAP Signaling with Metabolism.
Ibar C; Irvine KD
Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
[TBL] [Abstract][Full Text] [Related]
35. YAP activates the Hippo pathway in a negative feedback loop.
Dai X; Liu H; Shen S; Guo X; Yan H; Ji X; Li L; Huang J; Feng XH; Zhao B
Cell Res; 2015 Oct; 25(10):1175-8. PubMed ID: 26315483
[No Abstract] [Full Text] [Related]
36. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
37. Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation.
Lin Z; Pu WT
Stem Cell Res; 2014 Nov; 13(3 Pt B):571-81. PubMed ID: 24881775
[TBL] [Abstract][Full Text] [Related]
38. Neuregulin 1-activated ERBB4 as a "dedicated" receptor for the Hippo-YAP pathway.
Sudol M
Sci Signal; 2014 Dec; 7(355):pe29. PubMed ID: 25492964
[TBL] [Abstract][Full Text] [Related]
39. YAP and the Hippo pathway in cholangiocarcinoma.
Sugihara T; Isomoto H; Gores G; Smoot R
J Gastroenterol; 2019 Jun; 54(6):485-491. PubMed ID: 30815737
[TBL] [Abstract][Full Text] [Related]
40. The Hippo pathway in tissue homeostasis and regeneration.
Wang Y; Yu A; Yu FX
Protein Cell; 2017 May; 8(5):349-359. PubMed ID: 28130761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
